tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO

BridgeBio Pharma (BBIO) Revenue

Compare
1,431 Followers

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 120.70M in the quarter ending Sep 30, 2025, with 9.17%. This bring the company's revenue in the last twelve months to 353.78M, Decreased 50.03%. In the fiscal year ending Dec 31, 2024, BridgeBio Pharma had annual revenue of 221.90M with 2285.27% growth.
Revenue (ttm)
353.78M
Revenue Growth
62.46%
P/S Ratio
64.32
Revenue/Employee
$306,072
Employees
725
Market Cap
$14.27B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
221.90M212.60M+2,385.27%
Dec 31, 2023
9.30M-68.34M+11.98%
Dec 31, 2022
77.65M7.93M+111.38%
Dec 31, 2021
69.72M61.47M+845.14%
Dec 31, 2020
8.25M-32.31M+20.34%
Dec 31, 2019
40.56M-4,056,000,000.00%
Dec 31, 2018
Dec 31, 2017